Overview

A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Phase 2/3 open-label trial to assess the safety and tolerability of long-term treatment with lacosamide (SPM 927) in subjects with painful diabetic neuropathy. The safety and tolerability of the different doses of lacosamide will be investigated.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Lacosamide